1. , , , . A randomized, controlled, double-blind crossover study on the effects of 2-L infusions of 0.9% saline and plasma-lyte® 148 on renal blood flow velocity and renal cortical tissue perfusion in healthy volunteers. Ann Surg 2012; 256 : 18–24.
2. , , et al. Dilution and redistribution effects of rapid 2-litre infusions of 0.9% (w/v) saline and 5% (w/v) dextrose on haematological parameters and serum biochemistry in normal subjects: a double-blind crossover study. Clin Sci 2001; 101 : 173–9.
3. , , et al. Effects of volume loading with 1 liter intravenous infusions of 0.9% saline, 4% succinylated gelatine (Gelofusine) and 6% hydroxyethyl starch (Voluven) on blood volume and endocrine responses: a randomized, three-way crossover study in healthy volunteers. Crit Care Med 2010; 38 : 464–70.
4. , , et al. (Ab)normal saline and physiological Hartmann’s solution: a randomized double-blind crossover study. Clin Sci 2003; 104 : 17–24.
5. , , , et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008; 358 : 125–39.
6. , , , et al. Hydroxyethyl starch 130/0.42 versus Ringer’s acetate in severe sepsis. N Engl J Med 2012; 367 : 124–34.
7. , , , et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 2012; 367 : 1901–11.
8. , , et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004; 350 : 2247–56.
9. , , et al. Cardiac response is greater for colloid than saline fluid loading after cardiac or vascular surgery. Intensive Care Med 2006; 32 : 1030–8.
10. , , , . Crystalloid or colloid fluid loading and pulmonary permeability, edema, and injury in septic and nonseptic critically ill patients with hypovolemia. Crit Care Med 2009; 37 : 1275–81.
11. , . Microvascular fluid exchange and the revised Starling principle. Cardiovasc Res 2010; 87 : 198–210.
12. , , , . Broken barriers: a new take on sepsis pathogenesis. Sci Transl Med 2011; 3(88) : ps25.
13. , . Resuscitation fluids. N Engl J Med 2013; 369 : 1243–51.
14. , , , et al. Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and meta-analysis. JAMA 2013; 309 : 678–88.
15. , , , et al. Hydroxyethyl starch 130/0.38–0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-analysis and trial sequential analysis. Br Med J 2013; 346 : f839.
16. , . CONTRA: Hydroxeythyl starch solutions are unsafe in critically ill patients. Intensive Care Med 2009; 25 : 1337–42.
17. , , et al. Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA 2012; 308 : 1566–72.
18. et al. Hyperchloremia after noncardiac surgery is independently associated with increased morbidity and mortality: a propensity-matched cohort study. Anesth Analg 2013; 117 : 412–21.
19. , , , et al. The effects of balanced versus saline-based hetastarch and crystalloid solutions on acid-base and electrolyte status and gastric mucosal perfusion in elderly surgical patients. Anesth Analg 2001; 93 : 811–6.
20. , , et al. Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: The CRYSTMAS study. Crit Care 2012; 16 : R94.
22. , , , . Early postoperative respiratory acidosis after large intravascular volume infusion of lactated ringer’s solution during major spine surgery. Anesth Analg 2002; 95 : 294–8.
23. , , et al. Perioperative buffered versus non-buffered fluid administration for surgery in adults. Cochrane Database Syst Rev 2012; 12 : CD004089.
24. , et al. Fluid replacement with hydroxyethyl starch in critical care – a reassessment. Dtsch Arztebl Int 2013;110:443–50.
25. . Pruritis precipitated by hydroxyethyll starch: a review. Br J Dermatol 2005; 152 : 3–12.
26. , , . Randomised trials of 6% tetrastarch (hydroxyethyl starch 130/0.4 or 0.42) for severe sepsis reporting mortality: systematic review and meta-analysis. Intensive Care Med 2013; 39 : 811–22.
27. , , et al. Fluid resuscitation with 6% hydroxyethyl starch (130/0.4 and 130/0.42) in acutely ill patients: systematic review of effects on mortality and treatment with renal replacement therapy. Intensive Care Med 2013; 39 : 558–68.
28. , , et al. Incidence of post-operative death and acute kidney injury associated with intravenous 6% hydroxyethyl starch use: systematic review and meta-analysis. Br J Anaesth 2014; 112 : 25–34.
29. , . Colloid solutions for fluid resuscitation. Cochrane Database Syst Rev 2012; 7 : CD001319.
30. , , . Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 2013; 2 : CD000567.
31. , , , et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013; 41 : 580–637.
33. , . Debate: albumin administration should not be avoided. Crit Care 2000; 4 : 147–50.
34. , , et al. Human albumin solution for resuscitation and volume expansion in critically ill patients. Cochrane Database Syst Rev 2011; 11 : CD001208.
35. , , , et al. Saline or albumin for fluid resuscitation in patients with traumatic brain injury. N Engl J Med 2007; 357 : 874–84.
36. , , , . Effects of hydroxyethylstarch in subgroups of patients with severe sepsis: exploratory post-hoc analyses of a randomised trial. Intensive Care Med. 2013; 39 : 1963–71.
41. , , et al. Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality. Crit Care Med 2011; 29 : 259–65.
42. , . Intraoperative fluids: how much is too much?Br J Anaesthesia 2012; 109 : 69–79.
43. ; , , , et al. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 2006; 354 : 2564–75.